ArticleCancers2022

Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant Therapies.

Sanne J M Hoefnagel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.